In a world where market predictions are as changeable as the weather, top Wall Street analysts have unfurled their latest forecasts for a slew of top companies. Take a gander at these pearls of market wisdom and see if the winds of fortune are shifting in your favor.
Crunching the Numbers
- We kick off with Canaccord Genuity, who boosted CervoMed Inc.’s price target from $50 to $65. Analyst Sumant Kulkarni kept the faith with a Buy rating despite a 5.3% drop in CervoMed shares on Friday.
- Susquehanna set sail with an increased price target for Transocean Ltd. from $5.5 to $9. Analyst Charles Minervino raised the stock from Neutral to Positive waters, despite a 0.2% dip in Transocean shares at the week’s close.
- Truist Securities pumped up Sealed Air Corporation’s price target from $39 to $44, as analyst Michael Roxland upgraded the stock from Hold to Buy amidst a 1.7% descent in Sealed Air shares.
- Piper Sandler hiked Perrigo Company plc’s price target from $35 to $39. Analyst Korinne Wolfmeyer maintained an Overweight rating, even as Perrigo shares dipped 0.2% on Friday.
- Mizuho took a different path, cutting The Simply Good Foods Company’s price target from $50 to $40. Analyst John Baumgartner stuck to a Buy rating, despite a 1.6% slide in Simply Good Foods shares.
- Morgan Stanley caused ripples by increasing Shockwave Medical, Inc.’s price target from $285 to $335. Analyst Patrick Wood, however, downgraded the stock from Overweight to Equal-Weight, although Shockwave Medical shares managed to gain 2% by the week’s end.
- Evercore ISI Group took a bullish stance, raising The Walt Disney Company’s price target from $115 to $130. Analyst Vijay Jayant maintained an Outperform rating as Disney shares saw a 1.1% uptick on Friday.
- Goldman Sachs shone a spotlight on BJ’s Wholesale Club Holdings, Inc. by lifting the price target from $81 to $87. Analyst Kate McShane’s upgrade from Neutral to Buy failed to propel shares, as BJ’s Wholesale Club saw a 0.2% drop.
- Baird veered off course by slashing Douglas Dynamics, Inc.’s price target from $36 to $25. Despite the downgrade from Outperform to Neutral by analyst Timothy Wojs, shares managed to eke out a slight 0.2% gain.
- B of A Securities pumped some adrenaline into Huntington Bancshares Incorporated by increasing the price target from $14 to $16. Analyst Ebrahim Poonawala’s upgrade from Neutral to Buy nudged Huntington Bancshares shares up by 0.6%.
What a whirlwind of forecasts! Are these predictions the guiding stars for your financial voyage, or merely constellations in a vast sky of uncertainty? Dive into the data, chew on the numbers, and plot your own course through the tumultuous seas of the market.
Check This Out: Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
